Statistical strategies for the analysis of clinical trials with an experimental treatment, an active control and placebo, and a prespecified fixed non-inferiority margin for the difference in means

被引：7

作者：

Roehmel, Joachim ^{[1
]}

Pigeot, Iris ^{[1
]}

机构：

[1] Univ Bremen, Bremen Inst Prevent Res & Social Med, D-28359 Bremen, Germany

来源：

关键词：

GOLD STANDARD DESIGN; ESTABLISHING EFFICACY;

D O I：

10.1002/sim.4299

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：3162 / 3164

页数：3

共 13 条

[1] [Anonymous], 2011, ICH HARM TRIP GUID S
[2] Rejoinder to "Establishing efficacy of a new experimental treatment in the 'gold standard' design"
Hauschke, D
Pigeot, I
[J]. BIOMETRICAL JOURNAL, 2005, 47 (06) : 797 - 798
[3] Hauschke D, 2005, BIOMETRICAL J, V47, P782, DOI 10.1002/bimj.200510169
[4] On the three-arm non-inferiority trial including a placebo with a prespecified margin
Hida, Eisuke
Tango, Toshiro
[J]. STATISTICS IN MEDICINE, 2011, 30 (03) : 224 - 231
[5] Hung HMJ, 2005, BIOMETRICAL J, V47, P795, DOI 10.1002/bimj.200510180
[6] ICH, 2011, ICH HARM TRIP GUID C
[7] Discussion on "Establishing efficacy of a new experimental treatment in the 'gold standard' design"
Koch, A
[J]. BIOMETRICAL JOURNAL, 2005, 47 (06) : 792 - 793
[8] Koch Armin, 2004, J Biopharm Stat, V14, P315
[9] Lewis JA, 2005, BIOMETRICAL J, V47, P787, DOI 10.1002/bimj.200510182
[10] A group sequential type design for three-arm non-inferiority trials with binary endpoints
Li, Gang
Gao, Shan
[J]. BIOMETRICAL JOURNAL, 2010, 52 (04) : 504 - 518